Human Follistatin Quantikine ELISA Kit
| Name | Human Follistatin Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DFN00 |
| Category | ELISA Kit |
| Prices | $519.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (10 uL), Serum (100 uL), EDTA Plasma (100 uL), Follicular Fluid (10 uL) |
| Sensitivity | 83 pg/mL |
| Range | 250.0 - 16,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Follicular Fluid) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Follistatin Immunoassay is a 5.5 hour solid-phase ELISA designed to measure human Follistatin (FS288, FS300, and FS315) in follicular fluid, cell culture supernates, serum, and plasma |
| Gene | FST |
| Supplier Page | Shop |
Product images
Product References
In vitro drug testing based on contractile activity of C2C12 cells in an - In vitro drug testing based on contractile activity of C2C12 cells in an
Ikeda K, Ito A, Imada R, Sato M, Kawabe Y, Kamihira M. Sci Rep. 2017 Mar 16;7:44570.
The differential anti-tumour effects of zoledronic acid in breast cancer - - The differential anti-tumour effects of zoledronic acid in breast cancer -
Wilson C, Ottewell P, Coleman RE, Holen I. BMC Cancer. 2015 Feb 14;15:55.
Serum activin A and follistatin levels in gestational diabetes and the - Serum activin A and follistatin levels in gestational diabetes and the
Naf S, Escote X, Ballesteros M, Yanez RE, Simon-Muela I, Gil P, Albaiges G, Vendrell J, Megia A. PLoS One. 2014 Apr 24;9(4):e92175.
Follistatin: a novel therapeutic for the improvement of muscle regeneration. - Follistatin: a novel therapeutic for the improvement of muscle regeneration.
Yaden BC, Croy JE, Wang Y, Wilson JM, Datta-Mannan A, Shetler P, Milner A, Bryant HU, Andrews J, Dai G, Krishnan V. J Pharmacol Exp Ther. 2014 May;349(2):355-71.
The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity - The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity
Ferguson BW, Gao X, Zelazowski MJ, Lee J, Jeter CR, Abba MC, Aldaz CM. BMC Cancer. 2013 Dec 11;13:593.
BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface - BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface
Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T. PLoS One. 2012;7(6):e37697.
Relationship between bone mineral density and serum osteoprotegerin in patients - Relationship between bone mineral density and serum osteoprotegerin in patients
Chen YH, Wu YW, Yang WS, Wang SS, Lee CM, Chou NK, Hsu RB, Lin YH, Lin MS, Ho YL, Chen MF. PLoS One. 2012;7(8):e44242.
Exercise induces a marked increase in plasma follistatin: evidence that - Exercise induces a marked increase in plasma follistatin: evidence that
Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, Pedersen BK, Plomgaard P. Endocrinology. 2011 Jan;152(1):164-71.
Concentration of activin A and follistatin in follicular fluid from human small - Concentration of activin A and follistatin in follicular fluid from human small
Jeppesen JV, Nielsen ME, Kristensen SG, Yding Andersen C. Mol Cell Endocrinol. 2012 Jun 5;356(1-2):48-54.
Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and - Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and
Foley JW, Bercury SD, Finn P, Cheng SH, Scheule RK, Ziegler RJ. Mol Ther. 2010 Sep;18(9):1584-91.